These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3937212)

  • 41. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy of oxamniquine, praziquantel and a combination of both drugs in schistosomiasis mansoni in Brazil.
    Zwingenberger K; Queiroz JA; Poggensee U; Alencar JE; Valdegunas J; Esmeralda F; Feldmeier H
    Rev Inst Med Trop Sao Paulo; 1987; 29(5):305-11. PubMed ID: 3136533
    [No Abstract]   [Full Text] [Related]  

  • 43. Oxamniquine versus niridazole for treatment of uncomplicated Schistosoma mansoni infection.
    Kilpatrick ME; El Masry NA; Bassily S; Farid Z
    Am J Trop Med Hyg; 1982 Nov; 31(6):1164-7. PubMed ID: 7149102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in Ethiopia.
    Ayele T
    East Afr Med J; 1984 Aug; 61(8):632-6. PubMed ID: 6399027
    [No Abstract]   [Full Text] [Related]  

  • 45. Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.
    Gryseels B; Nkulikyinka L; Coosemans MH
    Trans R Soc Trop Med Hyg; 1987; 81(4):641-4. PubMed ID: 3127965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schistosoma mansoni cationic egg antigens (CEF6): immunoserology with oxamniquine-treated patients and involvement of CEF6 in the circumoval precipitin reaction.
    Dunne DW; Hillyer GV; Vazquez G
    Am J Trop Med Hyg; 1988 May; 38(3):508-14. PubMed ID: 3152779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N; Rocha RS
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):310-4. PubMed ID: 6762634
    [No Abstract]   [Full Text] [Related]  

  • 48. A review of clinical experience with oxamniquine.
    Foster R
    Trans R Soc Trop Med Hyg; 1987; 81(1):55-9. PubMed ID: 3127959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schistosoma mansoni treatment with oral oxamniquine in Zambia.
    Gupta KK
    East Afr Med J; 1984 Aug; 61(8):641-4. PubMed ID: 6399028
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of oxamniquine in treatment of S. mansoni in a closed community in Egypt and the concomitant administration of both metrifonate and oxamniquine in mixed infections.
    Saif M; Gaber A; Hassanein YS; Khameis S
    J Egypt Med Assoc; 1978; 61(5-6):427-31. PubMed ID: 400362
    [No Abstract]   [Full Text] [Related]  

  • 52. Further experience on the use of oxamniquine in the treatment of advanced intestinal schistosomiasis.
    Farid Z; Bassily S; Higashi GI; el-Masry NA; Watten RH; Trabolsi B
    Ann Trop Med Parasitol; 1979 Oct; 73(5):501-2. PubMed ID: 534452
    [No Abstract]   [Full Text] [Related]  

  • 53. [Oxamniquine in the treatment of Schistosoma mansoni infection].
    Kapend'a K; Odio W; Toko AL; Vandepitte J; Kayembe NN; Wane J
    Ann Soc Belg Med Trop; 1982; 62(3):213-9. PubMed ID: 7181541
    [No Abstract]   [Full Text] [Related]  

  • 54. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
    Branchini ML; Pedro Rde J; Dias LC; Deberaldini ER
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):315-21. PubMed ID: 6762635
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni by the oogram method with biopsy of rectal mucosa].
    da Cunha AS
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):88-94. PubMed ID: 6753086
    [No Abstract]   [Full Text] [Related]  

  • 56. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni.
    Katz N; Rocha RS; Chaves A
    Rev Inst Med Trop Sao Paulo; 1982; 24(1):40-8. PubMed ID: 6750759
    [No Abstract]   [Full Text] [Related]  

  • 57. Re: serious side effects of oxamniquine during the treatment of Schistosoma mansoni in Kenya.
    Okela GB
    East Afr Med J; 1985 Jul; 62(7):433. PubMed ID: 3935408
    [No Abstract]   [Full Text] [Related]  

  • 58. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B; Nkulikyinka L
    Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
    Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of specific therapy on the levels of schistosomiasis mansoni infection].
    Alvim Ade C
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():333. PubMed ID: 3151108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.